116 related articles for article (PubMed ID: 9111422)
41. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
42. Translocation t(1;3)(p36;q21) in malignant myeloid stem cell disorders.
Cambrin GR; Mecucci C; Van Orshoven A; Tricot G; Van den Berghe H
Cancer Genet Cytogenet; 1986 May; 22(1):75-81. PubMed ID: 3955532
[TBL] [Abstract][Full Text] [Related]
43. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cadman EC; Capizzi RL; Bertino JR
Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
[TBL] [Abstract][Full Text] [Related]
44. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
45. [Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study].
Schellong G; Hörnig-Franz I; Rath B; Ritter J; Riepenhausen M; Kabisch H; Goldschmitt-Wuttge B; Schmidt P; Niethammer D; Gaedicke G
Klin Padiatr; 1994; 206(4):253-62. PubMed ID: 7967421
[TBL] [Abstract][Full Text] [Related]
46. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
48. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
[TBL] [Abstract][Full Text] [Related]
49. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
50. Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Shah NK; Wingard JR; Piantadosi S; Rowley S; Santos G; Griffin CA
Cancer Genet Cytogenet; 1993 Feb; 65(2):135-40. PubMed ID: 8453599
[TBL] [Abstract][Full Text] [Related]
51. Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes?
Weh HJ; Hoffmann R; Suciu S; Kuse R; Hossfeld DK
Cancer Genet Cytogenet; 1988 Oct; 35(2):205-11. PubMed ID: 3180022
[TBL] [Abstract][Full Text] [Related]
52. In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia.
Raymakers R; De Witte T; Joziasse J; Van der Lely N; Boezeman J; Haanen C
Br J Haematol; 1991 May; 78(1):35-41. PubMed ID: 2043479
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Cramer P; Andrieu JM
J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
[TBL] [Abstract][Full Text] [Related]
55. Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease.
Weiner MA; Landmann RG; DeParedes L; Leventhal BG
J Pediatr Hematol Oncol; 1995 Nov; 17(4):338-41. PubMed ID: 7583390
[TBL] [Abstract][Full Text] [Related]
56. Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia.
Narod SA; Dubé ID
Cancer Genet Cytogenet; 1989 Apr; 38(2):261-9. PubMed ID: 2655887
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy.
Cimino G; Biti GP; Cartoni C; Magrini SM
Eur J Cancer; 1992; 28A(11):1853-5. PubMed ID: 1389525
[TBL] [Abstract][Full Text] [Related]
58. A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16.
Abbondanzo SL; Gray RG; Whang-Peng J; Jacobson RJ
Arch Pathol Lab Med; 1987 Apr; 111(4):330-2. PubMed ID: 3469939
[TBL] [Abstract][Full Text] [Related]
59. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
Lavey RS; Eby NL; Prosnitz LR
Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
[TBL] [Abstract][Full Text] [Related]
60. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
